U.S. stocks move | Moderna (MRNA.US) rises 7% after being included in the Nasdaq 100 Index

智通财经2026/10/09 15:56

Show original

According to information from Zhihui Finance APP, on Friday, Moderna (MRNA.US) surged as much as 10% during trading, reaching its highest share price since December 2022. As of press time, the gain narrowed to 7%, with the stock trading at $210.95. On the news front, on October 9, Moderna was officially included in the Nasdaq 100 index, replacing Warner Bros Discovery. After its inclusion, some broad-based institutions that previously did not allocate to biotech will now passively hold the stock, while active institutions will add the company to their watch lists, increasing attention on the individual stock.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.